Shaanxi Xinghua Chemistry Co (002109) Fair Value & Analysis
Basic Materials · CN · Market cap 3.4B CNY
Fair value as of: Jul 22, 2026
From 4 valuation models · updated today
Price vs Fair Value (12 months)
12‑month range ¥2.37 – ¥5.28 · fair‑value band ¥1.76 – ¥6.78 · the ¥2.52 price screens below the ¥3.92 fair value. As of Jul 22, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Shaanxi Xinghua Chemistry Co (002109) currently trades at ¥2.52, while our model-based Fair Value estimate is ¥3.92, implying the stock looks roughly 55.6% undervalued today. We read business quality at 27/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Shaanxi Xinghua Chemistry Co generated revenue of 3.8B CNY at a net margin of -10.7%. Revenue grew 27.5% year over year. It earns a return on equity of -10.7%. Net debt stands at 2.4B CNY. Fundamentals as of Jul 22, 2026
Our scenario range runs from ¥1.76 (bear case) to ¥6.78 (bull case); at ¥2.52, the current price sits within that range. The share trades about 54% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -57% fair-value upside, at 56%, 002109 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 22, 2026. TTM = trailing twelve months.
About the company
Shaanxi Xinghua Chemistry Co.,Ltd produces and sells ammonium nitrate products in China. It also offers liquid ammonia, methanol, methylamine, dimethylformamide, ethanol, and other products. The company was founded in 1997 and is based in Xingping, China.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Shaanxi Xinghua Chemistry Co reported revenue of ¥3.5B in FY2025 versus ¥2.8B in FY2021, a compound +5.8%/yr. Reported net income was −¥517M in FY2025.
Is 002109 fairly valued? → Check now
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €443.00 | €109.98 | -75% |
| BASF SE BASN | 1,034 MXN | 23.76 MXN | -98% |
| Ningxia Baofeng Energy Group 600989 | ¥21.72 | ¥42.42 | +95% |
| Dow Inc D1OW34 | R$41.12 | R$16.66 | -59% |
| Zhejiang Juhua Co 600160 | ¥48.53 | ¥20.70 | -57% |
| Rongsheng Petrochemical Co 002493 | ¥11.15 | ¥3.01 | -73% |
| PT Barito Pacific Tbk, BRPT | 1,760 IDR | 1,596 IDR | -9% |
| Zangge Mining Company 000408 | ¥78.96 | ¥50.88 | -36% |
| Ganfeng Lithium Group 002460 | ¥72.05 | ¥21.69 | -70% |
| Hengli Petrochemical Co 600346 | ¥18.65 | ¥43.28 | +132% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Shaanxi Xinghua Chemistry Co (002109) undervalued?
What is the fair value of 002109?
What is the quality score of 002109?
What is the revenue of Shaanxi Xinghua Chemistry Co (002109)?
What is the net profit margin of 002109?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Shaanxi Xinghua Chemistry Co analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.